Back to Results
First PageMeta Content
Clinical research / Health / Drug discovery / Pharmaceutical industry / Pharmaceuticals policy / Prescription Drug User Fee Act / FDA Fast Track Development Program / Center for Drug Evaluation and Research / Biologic / Food and Drug Administration / Pharmaceutical sciences / Pharmacology


Richard Moscicki - Priorities for CDER[removed]
Add to Reading List

Open Document

File Size: 423,67 KB

Share Result on Facebook

Company

Sentinel / /

Event

FDA Phase / /

Facility

Facility Remediation Efforts Quality / Pharmacy Compounding Rethinking Pharmaceutical Quality Improve Drug Labels Drug Safety / /

IndustryTerm

chemical entities / biological products / Treatment of Serious Bacterial Diseases / /

MedicalCondition

tumor / melanoma / serious diseases / Rare diseases / Common disease / Serious Bacterial Diseases / Rare Disease / serious/life‐threatening disease / /

Organization

FDA / /

Person

Richard Moscicki / /

Position

Deputy Center Director / /

Product

Antibacterial Drug / Breakthrough / /

ProgrammingLanguage

R / /

Technology

Drug Development / API / /

SocialTag